Sudafed PE Sinus Congestion Relief Tablets, 10 mg Phenylephrine HCI, 36 Ct

Description

Brand: Sudafed

Color: Red

Features:

• Sinus pressure & congestion relief: 36-count package of Sudafed PE sinus congestion maximum strength; a non-drowsy decongestant tablet for fast and relief of sinus pressure and sinus and nasal congestion
• Non-drowsy cold & sinus medicine: Sudafed sinus congestion and cold relief medication helps to temporarily relieve nasal congestion associated with hay fever, upper respiratory allergies and the common cold
• Phenylephrine HCl formula: each sinus pressure relief tablet has 10 mg of phenylephrine HCl, a nasal decongestant to provide fast symptom relief; it reduces nasal swelling to help you breathe easier
• How to use: Sudafed PE sinus congestion tablets can be used by adults and children ages 12 and up; take one nasal decongestant tablet every four hours; do not exceed six tablets within a 24 hour time period
• FSA HSA approved product**: Sinus pressure due to cold and allergies medicine from Sudafed, the #1 pharmacist recommended brand among oral OTC decongestants. ** Check your plan for details as plans may vary.

Package Dimensions: 17x114x18

Release Date: 04-02-2016

Details: Get nasal congestion and sinus pressure relief with Sudafed PE Sinus Congestion Tablets. From the #1 pharmacist recommended brand among oral OTC decongestants*, each maximum strength sinus tablet contains 10 mg of the nasal decongestant phenylephrine HCl to help provide sinus pressure relief and reduce swelling of nasal passages so you can breathe easier. The non-drowsy formula also temporarily relieves sinus pressure and nasal congestion due to the common cold, hay fever or other respiratory allergies. These maximum strength nasal decongestant tablets can be used by adults and children 12 years and older for fast sinus pressure and congestion relief. Take one tablet every 4 hours; do not exceed six tablets within a 24 hour time period. Sudafed PE Sinus Congestion is HSA & FSA eligible. Check your plan for details as plans may vary. *US News & World Report/Pharmacy Times 2024-2025

UPC: 300450581365